Abstract:BackgroundFibroblastic foci are characteristic features in lung parenchyma of patients with idiopathic pulmonary fibrosis (IPF). They comprise aggregates of mesenchymal cells which underlie sites of unresolved epithelial injury and are associated with progression of fibrosis. However, the cellular origins of these mesenchymal phenotypes remain unclear. We examined whether the potent fibrogenic cytokine TGF-β1 could induce epithelial mesenchymal transition (EMT) in the human alveolar epithelial cell line, A549, and investigated the signaling pathway of TGF-β1-mediated EMT.MethodsA549 cells were examined for evidence of EMT after treatment with TGF-β1. EMT was assessed by: morphology under phase-contrast microscopy; Western analysis of cell lysates for expression of mesenchymal phenotypic markers including fibronectin EDA (Fn-EDA), and expression of epithelial phenotypic markers including E-cadherin (E-cad). Markers of fibrogenesis, including collagens and connective tissue growth factor (CTGF) were also evaluated by measuring mRNA level using RT-PCR, and protein by immunofluorescence or Western blotting. Signaling pathways for EMT were characterized by Western analysis of cell lysates using monoclonal antibodies to detect phosphorylated Erk1/2 and Smad2 after TGF-β1 treatment in the presence or absence of MEK inhibitors. The role of Smad2 in TGF-β1-mediated EMT was investigated using siRNA.ResultsThe data showed that TGF-β1, but not TNF-α or IL-1β, induced A549 cells with an alveolar epithelial type II cell phenotype to undergo EMT in a time-and concentration-dependent manner. The process of EMT was accompanied by morphological alteration and expression of the fibroblast phenotypic markers Fn-EDA and vimentin, concomitant with a downregulation of the epithelial phenotype marker E-cad. Furthermore, cells that had undergone EMT showed enhanced expression of markers of fibrogenesis including collagens type I and III and CTGF. MMP-2 expression was also evidenced. TGF-β1-induced EMT occurred through phosphorylation of Smad2 and was inhibited by Smad2 gene silencing; MEK inhibitors failed to attenuate either EMT-associated Smad2 phosphorylation or the observed phenotypic changes.ConclusionOur study shows that TGF-β1 induces A549 alveolar epithelial cells to undergo EMT via Smad2 activation. Our data support the concept of EMT in lung epithelial cells, and suggest the need for further studies to investigate the phenomenon.

Research of TGF-beta1 Inducing Lung Adencarcinoma PC9 Cells to Mesenchymal Cells Transition

Transforming Growth Factor-Β1 Promotes Lung Adenocarcinoma Invasion and Metastasis by Epithelial-to-mesenchymal Transition

Transforming Growth Factor-Beta 1 Induces Epithelial-To-Mesenchymal Transition In Human Lung Cancer Cells Via Pi3k/Akt And Mek/Erk1/2 Signaling Pathways

Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways

TGF-β1-induced Epithelial-mesenchymel Transition in Human Prostate Cancer Cells PC3

bFGF Induced Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cell Line A549

Epithelial-mesenchymal Transition of Type Ⅱ Alveolar Epithelial Cells Induced by TGF-β1

TGF-β1 induces human alveolar epithelial to mesenchymal cell transition (EMT)

Transforming Growth Factor-Β1 Induced Epithelial-Mesenchymal Transition in Hepatic Fibrosis.

The ratio of transforming growth factor-β1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis.

Effects of Transforming Growth Factor-Β on the Expressions of Epithelial-to-mesenchymal Transition-Related Molecules in A431 Cells

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.

Transforming Growth Factor-Β and Epithelial–mesenchymal Transition Are Associated with Pulmonary Metastasis in Adenoid Cystic Carcinoma

TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases Via Downregulation of Non Muscle Myosin II-A Through JNK/P38/PI3K Pathway in Lung Cancer.

Effect of Epithelial-to-mesenchymal Transition on the Invasion and Migration Abilities of Lung Squamous Cell Carcinoma

Roles of p38 MAPK and JNK in TGF-β1-induced alveolar epithelial to mesenchymal transition

Response Gene To Complement-32 Mediates Tgf-Beta-Induced Epithelial-Mesenchymal Transition Via Erk-/P38-Mapk Signaling Pathways In Human Pancreatic Cancer Cell Line Bxpc-3

Transforming Growth Factor-Β1 Regulates Epithelial-Mesenchymal Transition in Association with Cancer Stem-Like Cells in a Breast Cancer Cell Line.

Roles of p38 MAPK and JNK in TGF-β1-induced human alveolar epithelial to mesenchymal transition.

Transforming Growth Factor-Β1 Generates Epithelial-to-mesenchymal Transition and Promote CD44 Expression in SGC7901 Cells

TCTP Promotes Epithelial-Mesenchymal Transition in Lung Adenocarcinoma.